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Dipterex Teratogenicity in the Rat,
Hamster, and Mouse When Given by
Gavage
by R. E. Staples*t and E. H. Goulding*
Dipterex was teratogenic after administration by gavage (t.i.d.) at a dose level of 480 mg/kg-day to the
CD rat on days 6 through 15 ofgestation, but not when administered only on days 8 or 10 ofgestation. A
positive teratogenic response also occurred in the hamster after administration on days 7 through 11 of
gestation at 400 mg/kg-day; the apparent no-effect level for the criteria studied was 200 mg/kg-day.
Embryotoxicity, but not teratogenicity, occurred after administration at 400 mg/kg-day on day 8 of
gestation. In both species, the teratogenicity seen was not merely due to reduced maternal food consump-
tion during the period of exposure. The mouse was less susceptible to Dipterex than were the rat and
hamster, but a significant increase in the incidence of cleft palates resulted from exposure on days 10
through 14, or on days 12 through 14 of gestation.
Dipterex (0, 0-dimethyl-l-hydroxy-2,2,2-tri-
chloroethyl phosphonate) was found to be
teratogenic when consumed by rats on days 6
through 15 of gestation but not after administration
by gavage, once daily (i.d.), for the same period of
gestation (1). Since drugs, pesticides, and other en-
vironmental agents often are tested for teratogenic
potential only by gavage, it was considered impor-
tant to demonstrate whether the teratogenic poten-
tial ofDipterex could be detected in the rat by gav-
agethroughmultiple dailyadministration asameansof
attaining higher daily dose levels of Dipterex more
comparable to that achieved through incorporation in
the diet.
In the rat the teratogenicity ofDipterex was dem-
onstrated only at dose levels that decreased mater-
nal food consumption and that were far in excess of
expected levels of routine human exposure. To de-
termine whether the teratogenicity of Dipterex is
unique to the rat, its teratogenic potential also was
investigated in the hamster and the mouse.
* Environmental Toxicology Branch, National Institute of
Environmental Health Sciences, P. 0. Box 12233, Research
Triangle Park, North Carolina 27709.
t Present address: Haskell Laboratory for Toxicological and
Industrial Medicine, E. I. duPont deNemours & Company, Inc.,
Elkton Rd., Newark, Delaware 19711.
Material and Methods
Rats
Nonparous, female rats (CD strain) were housed
overnight with mature males of the same strain in
quarters lighted for 12 hr of each day and main-
tained at 20°C (50% RH). Mating was confirmed by
detection of spermatozoa in the vaginal lavage the
following morning (day 1 of gestation). Between
days 1 and 6 of gestation, all rats were caged indi-
vidually and had free access to water and Wayne
Lab Blox. On day 6 of gestation, the rats were as-
signed to the experimental group or to the pair-fed
control group (CPF). Dipterex was given by gavage
on days 6 through 15 ofgestation at adaily dose on a
par with those that were teratogenic in the first
study (1). Preliminary study revealed that ifthe rats
were gavaged three times daily (t.i.d.) a daily dose
of 480 mg/kg was tolerated quite well. The rats of
the experimental group were gavaged (t.i.d.) with
160 mg/kg body weight in 10 ml/kg of0.5% methyl-
cellulose in distilled water; the CPF group was gav-
aged similarly with only the vehicle.
To determine whether the teratogenicity of Dip-
terex could be revealed by gavage (t.i.d.) on a single
day during organogenesis, additional rats were
given Dipterex only on day 8 or 10 of gestation. In
this part ofthe study, the rats in the respective con-
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but they were not pair-fed to the experimental
groups.
Hamsters
Nonparous golden hamster females arrived from
Lakeview Farms, New Jersey on day 3 ofgestation.
The morning after mating was considered to be day
1 of gestation. They were housed individually in
plastic cages with corn cob bedding and had free
access to Wayne Lab Blox and water. Room tem-
perature was maintained at 20°C (50%o RH) and light
was provided for 12 hr of each 24 hr.
Dipterex was administered by gavage (t.i.d.) in 10
ml/kg body weight of distilled water from day 7 to
day 11. It was established by preliminary study that
the hamster would tolerate 400 mg/kg-day for this
period of gestation. The Dipterex solution was
freshly prepared each day and the daily dose was
administered in thirds at 9:00, 12:30, and 16:00 hrof
each exposure day. Concurrent control groups in-
cluded untreated controls (C) and another group
that was given only distilled water by gavage (t.i.d.)
at 10 ml/kg-day ondays 7through 11 ofgestation (Cv).
Lagging one day behind was a third control group
(CPF) that was pair-fed to the group given Dipterex
at 400 mg/kg-day. The CPF group also was gavaged
(t.i.d.) with distilled water on days 7 through 11 of
gestation. Food consumption was measured daily,
and maternal body weights were recorded on days
3, 7, 9, 11, 13, and 15 of gestation.
Upon completion of the experiment described
above, lower dose levels were added (100, 200, 300
mg/kg-day) to determine the apparent no-effect
dose level with respect to the criteria under study,
and the 400 mg/kg-day dose level was administered
by gavage (t.i.d.) to additional hamsters only on day
8 to determine fetal sensitivity to exposure on a
single day ofgestation.
Mice
Nonparous, female mice (CD-1 strain) were
cohabited overnight with mature males ofthe same
strain (2W/cj) in quarters lighted for 12 hr of each
day and maintained at 20°C (50%o RH). Mated females
detected by the presence of copulatory plugs in
their vaginas (considered to be day 1 ofgestation),
were housed in large plastic cages and had free ac-
cess to Wayne Lab Blox and water. All females
were housed individually beginning with the first
scheduled administration ofDipterex and thereafter
to permit measurement of food consumption until
two days after the last day ofexposure to Dipterex.
It was established by preliminary study that preg-
nant mice could tolerate Dipterex in doses up to 600
mg/kg-day for four consecutive days if given by
gavage (t.i.d.). On this basis groups of pregnant
mice were given Dipterex at a dose level of 600
mg/kg-day on days 6 through 10 and on days 10
through 14 of gestation. Again the apparent no-
effect dose level was determined by study of addi-
tional dose levels (300, 400, and 500 mg/kg-day) ad-
ministered for the same periods, and fetal sensitiv-
ity to shorter exposure periods was explored by
administration of Dipterex at the dose level of 600
mg/kg-day on day 8, days 8 through 10, days 10
through 12, and days 12 through 14ofgestation. The
Dipterex solutions were prepared each day in dis-
tilled water such that the desired dosage could be
administered in 10 mI/kg body weight at 9:00, 12:30,
and 16:00 hr daily. Groups of control females (Cv)
were given the same volume of distilled water by
gavage (t.i.d.) for the same periods of gestation as
for the groups given Dipterex; other groups ofcon-
trol females (C) were not gavaged. Maternal body
weight was measured on day 1 of gestation, on the
first day of Dipterex administration, every other
day during dosing, the second day after cessation of
Dipterex administration, and onthe day ofsacrifice.
On day 21 ofgestation for the rats, on day 15 for
the hamsters, on day 18 for the mice, all females
were coded and sacrificed (by CO2 inhalation forthe
hamsters, and by CO2 inhalation followed by cervi-
cal dislocation for the rats and mice), and their re-
productive status was determined. Implantation
sites in each uterine horn were counted and each
conceptus was recorded as being alive or dead and
as to general condition. Live fetuses were weighed
individually, sexed externally and internally, and
examined for external malformations. Those
weighing 2.0 g or less for rats, 1.0 g or less for
hamsters, and 0.5 g or less for mice, and those
weighing less than two-thirds the mean of their
larger litter mates were termed "stunted." At least
one-third ofthe fetuses ofeach litter, all "stunted"
fetuses, and those having external malformations
were dissected and examined for visceral alter-
ations (2); theirheads were fixed in Bouin's solution
and sliced to reveal developmental alterations. All
fetuses alive at sacrifice were cleared for visualiza-
tion of skeletal alterations (3).
Statistics
Nonparametric test procedures were used in the
data analysis. The litter was considered to be the
experimental unit and incidence data were ex-
pressed as mean percent affected fetuses per litter.
Experimental groups were compared to controls
(Cv and CPF) by Mann-Whitney U tests (4). One-
Environmental Health Perspectives 106sided tests were used, and differences significant at
the 0.05 level were noted.
Results
Rats
Signs of cholinesterase inhibition were evident
after each administration of Dipterex by gavage as
was reported previously (1). The effects did not ac-
cumulate from day to day and as a result only three
ofthe 34 females given Dipterex (t.i.d.) for 10 days
died between days 13 and 15 of gestation. None of
those given Dipterex only for one day died.
Dipterex administration to rats by gavage (t.i.d.)
on days 6 through 15 ofgestation was followed by a
substantial, although not a statistically significant,
decrease in the maintenance of pregnancy, an in-
crease in the fetal mortality rate (p = 0.06) among
rats in which pregnancy was maintained, and a sig-
nificant decrease in the body weight ofthe surviving
fetuses versus values for the same criteria among
pair-fed control rats (Table 1). Furthermore, an av-
erage of 76.4% of the fetuses in each litter of the
experimental group was malformed. The malforma-
tions occurred in all of the 19 litters exposed to
Dipterex and consisted mostly of generalized
edema, various types of herniation ofthe brain and
cerebrospinal fluid through the skull, internal hy-
drocephaly, micrognathia, cleft palate, severely
shortened radius and ulna, and hypophalangism and
syndactyly. Other alterations noted were
hematomas, extensive doubling of the thoracic
centra, fusions of the sternebrae and of the ribs,
umbilical hernias, small kidneys and common trun-
cus. The malformations seen in the CPF group con-
sisted of two fetuses with wavy ribs and another
with doubled thoracic centra; these fetuses were
from three litters.
On the other hand, administration by gavage
(t.i.d.) of the same daily dose of Dipterex on day 8
or 10 of gestation significantly decreased maternal
food consumption, on a temporary basis (one day
period), but did not have a significant adverse effect
on the remaining criteria studied (Table 1).
Hamsters
Ten minutes after administration of Dipterex at
400 mg/kg-day by gavage (t.i.d.) the hamsters ex-
hibited signs of cholinesterase inhibition, e.g.,
ptyalism, exophthalmos, loss of equilibrium, and
muscular tremors. In general, they recovered by the
time the nextdose was to be administered, but three
ofthe 30 females given Dipterex (days 7 through 11)
at this level died; one afterthe first and two after the
third day of dosing. None of the control animals
died before scheduled sacrifice.
The maintenance of pregnancy was not adversely
affected by Dipterex administration on days 7
through 11 of gestation, but food consumption and
maternal weight gain were significantly reduced
below the values for both the Cv and CPF groups
and the incidence of fetal death, stunted, and mal-
Table 1. Effect of Dipterex administration by gavage (t.i.d.) to C-D rats for various periods of gestation.
Days 6-15
480 Day 8 or 10 Day 8, Day 10,
CPP mg/kg-dayb Cvc 480 mg/kg" 480 mg/kg"
Females
Total number 11 34 10 14 14
Mortality (%) 1(9) 3(9) 1(10) 0 0
Number pregnant (%) 8(80) 20(65)Y 9(100) 13(93) 12(86)
Food intake, ge 17.5 t 0.94 17.4 t 0.54 24 + 0.6 21 t 0.8f 23 ± 0.5f
Weight gain, ge I + 4.4 1 ± 4.7 0.2 ± 2.60 2.0 + 3.72
0.5 ± 3.01 - 1.5 ± 1.82
Fetuses
Total number 70 124 105 170 150
Fetal death, % ± SE 14(21 t 8.6) 71(38 + 6.5)9 1(0.9 + 0.93) 5(2.6 ± 1.62) 4(2.5 1.96)
Number stunted 2 1 1 0 1
Weight, g 3.4 0.11 2.8 0.11 f 3.9 0.13 3.9 ± 0.07 3.8 0.06
Number malformed (%) 5(6 ± 4.1) 86(76.4 ± 8.4)' 6(6 ± 4.7) 2(1 ± 0.8) 2(2 ± 1.7)
a CPF: a group given only the vehicle by gavage on days 6 through 15 of gestation and pair-fed to the corresponding group given
Dipterex.
b Daily dosage of Dipterex given in mg/kg-day.
c Cv: a combination of two groups of rats given only the vehicle by gavage on day 8 or 10 ofgestation.
d One female had 13 resorptions but no fetuses.
e Included the period gavaged plus two more days (X + SE).
'p < 0.05 compared to controls.
op = 0.06.
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100 200 300 400
Ca Cvb mg/kg-day mg/kg-day mg/kg-day mg/kg-day CPF'
Females
Total number 33 22 5 25(2) 10 30(3) 16
(deaths)
Numberpregnant 31 20 5 22 10 27 16
Food intake, gd 10.8 + 0.48 10.7 ± 0.31 10.8 ± 0.31 10.6 ± 0.22 8.6 ± 0.50e 7.0 ± 0.38e 7.2 ± 0.47e
Weight gain, gd 17.1 + 0.99 17.8 ± 0.95 18.2 ± 2.20 15.5 ± 1.40 9.3 ± 3.14e 5.7 ± 2.1Oef 12.5 ± 1.5le
Fetuses
Total number 339 208 49 238 105 225 181
Numberperfemale 10.9 ± 0.36 10.4 ± 0.42 10.0 ± 0.71 10.8 ± 0.35 10.5 ± 0.70 8.6 ± 0.55ef 11.3 ± 0.45
Fetal deaths 17/12 10/8 5/2 13/8 16/5 77/19 11/6
(no. dead/no. litters)
Fetal death, % 17(4.9 1.34) 10(4.6 ± 1.46) 5(9.1 ± 4.98) 13(5.0 ± 1.48) 16(12.6 ± 5.08) 77(24.5 ± 4.50)ef 11(5.5 ± 2.28)
Numberstunted 1 3 0 2 1 12 0
Weight, g 1.90 ± .026 1.89 ± 0.042 2.02 ± 0.075 1.89 ± 0.037 1.75 ± 0.059e 1.57 ± 0.047ef 1.86 ± 0.040
Numbermalformed 1 3 1 4 1 13 1
Percent malformed 0.39 ± 0.390 1.29 ± 0.928 2.20 ± 2.200 1.45 ± 0.673 1.00 ± 1.00 8.98 ± 3.947e 0.44 ± 0.440
a C: group notgavaged.
b Cv: groupgavaged (t.i.d.) withdistilled waterforthe days indicated
c CPF: group gavaged and pair-fed to the Dipterex group given 41
d Included period gavaged plus two more days (X ± SE).
" p < 0.05 compared to Cv.
fp< 0.05 compared to CPF.
formed fetuses was significantly increased among
the litters of the Dipterex group (Table 2). Most of
the malformations consisted ofedema, cleft palate,
patagium, and fused ribs (Table 3). The hemimelic
fetus had no radius or ulna in the left front limb, and
the tibia in the left hind limb was only one-half the
length of that in the right hind limb; the distal por-
tion was missing. In addition, this stunted fetus had
a cleft palate, bilateral cleft lip, micrognathia, and
both fused and doubled thoracic and lumbar centra.
The pulmonary trunk of another fetus led from the
right ventricle under the aortic arch and inserted
into the right subclavian artery instead of into the
descending aorta via the ductus arteriosus. The ec-
trodactyly seen in both the Cv and Dipterex groups
consisted of missing thumbs.
Administration of Dipterex on days 7 through 11
of gestation at a dose level of 300 mg/kg-day also
resulted in significantly lower food consumption,
maternal weight gain, and fetal weight upon com-
parison to the values for the Cv group (Table 2).
Fetal lethality was increased, but the difference
from that of the control group was not statistically
significant. Only one malformed fetus was seen
among the fetuses of the group given Dipterex at
300 mg/kg-day, but it had several severe malforma-
tions (Table 3).
In the group given Dipterex at 200 mg/kg-day,
two females died between the end of the dosing
period and scheduled sacrifice. During the dosing
period signs of cholinesterase inhibition, while still
present, were not as severe as those seen after ad-
ministration at 400 mg/kg-day. Additional statisti-
cally significant differences were not seen between
the 200 mg/kg group and the Cv group (Tables 2 and
3).
After Dipterex administration only on day 8 of
gestation at 400 mg/kg-day, maternal food con-
sumption was significantly decreased and fetal le-
thality was significantly increased upon comparison
to the corresponding Cv group (Table 4). None of
the remaining criteria studied differed significantly
between the two groups.
Mice
Dipterex was administered to mice at 600 mg/kg-
day, but even at this dose level overt signs of
cholinesterase inhibition were not noted. Four ofthe
females given Dipterex at this level for some period
of gestation died before scheduled sacrifice but no
more than one occurred in each group. Higher dose
levels were not studied because afteradministration
at 600 mg/kg-day for five days both maternal food
intake and rate ofgain in body weight were signifi-
cantly reduced (Table 5).
Although maternal food consumption and weight
gain were significantly reduced after administration
of the highest levels of Dipterex on days 6 through
10 of gestation, adverse effects were not detected
on maintenance of pregnancy, fetal survival, or on
incidence of stunting (Table 5). Fetal weight was
significantly reduced at dose levels of 400 mg/kg-
day or more, but the total incidence of develop-
mental malformations was not increased above
control values (Tables 5 and 6). Administration of
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Days 7 through 11 Day 8
100 200 300 400 400
C' CvO mg/kg-day mg/kg-day mg/kg-day mg/kg-day CPP Cvb mg/kg
Number of fetuses/number of litters examined
External alterations 356/31 218/20 54/5 251/22 121/10 302/27 192/16 161/14 225/22
Visceral alterations 144/31 83/20 21/5 95/22 43/10 119/27 73/16 63/14 96/22
Skeletal alterations 356/31 218/20 54/5 251/22 121/10 302/27 192/16 161/14 225/22
Number of fetuses affected/number of litters affected
External examination
Edema 3/2
Cleft lip 1/1
Cleft palate 1/1 3/3
Ectrocardia 1/1
Micrognathia 1/1
Microphthalmia 1/1
Hemimely 1/1
Ectrodactyly 1/1 1/1 2/1
Patagium 4/4
Tailed kinked 1/1
Hematoma 1/1
Visceral examination
Pulmonary trunk displacement 1/1
Innominate, absent 1/1 1/1
Pancreas agenesis 1/1
Spleen agenesis 1/1
Kidney, small 1/1 1/1 1/1 1/1
Lungs, small 1/1
Skeletal examination
Vertebrae centra fused 1/1 1/1
Vertebrae centra doubled 1/1
Vertebrae centra misaligned 1/1
Ribs fused 2/2 2/2 1/1 3/3
Ribs branched 1/1
Sternebrae fused 1/1 1/1 1/1
Total 1/1 3/2 1/1 4/4 1/ 1 13/10" 1/1 1/1 4/4
" C: group not gavaged.
b CV: group gavaged (t.i.d.) with distilled water for the days indicated.
' CPF: group gavaged and pair-fed to the Dipterex group given 400 mg/kg.
d p < 0.05 compared to Cv.
e p < 0.05 compared to CPF.
Dipterex on days 10 through 14 was accompanied
by similar maternal and fetal effects, however, the
incidence of stunting was significantly increased at
the 600 mg/kg-day dose level and at both the 500 and
600 mg/kg-day levels the incidence of development
alterations was significantly increased (Table 7).
The increase in developmental alterations consisted
largely of cleft palates (Table 6); in the 500 mg/kg
dose group only one ofthe cleft palates occurred in
fetuses weighing less than 0.75 g, but in the 600
mg/kg dose group three ofthe five fetuses with cleft
palates were stunted and only one weighed more
than 0.75 g. In the 300 mg/kg dose group all alter-
ations except the doubled centra occurred in only
one fetus.
After administration of Dipterex to mice at 600
mg/kg for three or less days of gestation a statisti-
cally significant increase in cleft palate occurred
among nonstunted fetuses in the group dosed on
Table 4. Effect of Dipterex administration by gavage (t.i.d.) to
hamsters on day 8 of gestation.
CvI"' 400 mg/kg
Females
Total number (deaths) 16 23
Number pregnant 14 22
Food intake, g" 10.2 t 0.51 8.9 t 0.36
Weight gain, g' 6.0 t 1.28 4.1 t 0.82
Fetuses
Total number 155 237
Number per female 11.1 ± 0.67 10.8 t 0.54
Fetal death (no. dead/ 6/4 18/13
no. litters)
Fetal death, % 6(3.3 t 1.35) 18(7.1 t 1.64)'
Number stunted 1 2
Weight, g 1.91 ± 0.043 1.87 ± 0.033
Number malformed 1 4
Percent malformed 0.64 t 0.640 1.76 t 0.855
"Cv-group gavaged (t.i.d.) with distilled water on day 8.
Included day 8 plus two more days (X ± SE).
'p < 0.05 compared to Cv.
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300 400 500 600
C" Cv" mg/kg-day mg/kg-day mg/kg-day mg/kg-day
Females
Number pregnant 13 16 5 3 4 25
Food intake, g' 6.3 ± 0.16 6.2 ± 0.12 5.2 0.20d 6.1 ± 0.55 5.4 ± 0.25" 5.3 ± 0.11"
Weight gain, gc 4.6 ± 0.56 3.3 ± 0.44 1.4 ± 0.80 2.1 ± 0.98 1.7 + 1.06" 1.6 ± 0.35
Fetuses
Total number(%) i44(1.1) 187(11.7) 53(10.6) 39(13.0) 46(11.5) 270(10.8)
Fetal death, % 12.7 ± 3.54 11.6 + 2.60 3.7 ± 2.26 15.4 ± 1.80 4.4 + 2.70 9.9 ± 2.00
Number stunted (%) 0 1(0.53) 1(1.89) 0 1(2.17) 1(0.37)
Weight, g 0.89 ± 0.016 0.87 ± 0.012 0.88 + 0.067 0.74 + 0.009" 0.84 t 0.027" 0.82 ± 0.015"
Number malformed (%) 1(1.0 ± 0.96) 1(0.7 ± 0.69) 2(3.1 ± 3.08) 0 1(3.1 + 3.12) 3(2.1 + 1.28)
" C; group not gavaged.
b CV: group gavaged (t.i.d.) with distilled water for days indicated.
'Included the period gavaged plus two more days (X + SE).
p < 0.05.
Table 6. Incidence of alterations among the fetuses of CD-1 mice given Dipterex by gavage (t.i.d.) on days 6-10 of gestation.
Days 6-10 Days 10-14
300 400 500 600 300 400 500 600
mg/kg- mg/kg- mg/kg- mg/kg- mg/kg- mg/kg- mg/kg- mg/kg-
C Cv day day day day C Cv day day day day
Number of fetuses/number of litters examined
External alterations 144/13 187/16 53/5 39/3 46/4 270/25 135/12 267/23 91/7 44/4 67/6 205/20
Visceral alterations 57/13 67/16 20/5 14/3 16/4 100/25 52/12 101/23 33/7 16/4 27/6 88/20
Skeletal alterations 144/13 187/16 53/5 39/3 46/4 270/25 135/12 267/23 91/7 44/4 67/6 205/20
External examination
Cleft palate 1/1 1/1 1/1 1/1 1/1 3/2* 5/5*
Exencephaly 1/1
Ablepharia 1/1
Umbilical hernia 1/1
Kinked tail 1/1 1/1
Clubbed limbs 1/1 1/1
Hematoma 2/1 1/1
Visceral examination
Hydrocephaly 1/1 1/1
Testes small 1/1
Lungs small
Skeletal examination
Vertebrae fused
arch 1/1
Vertebrae doubled 1/1
centra
Ribs missing 1/1
Ribs wavy 2/2
Sternebrae fused
Total affected 1/1 1/1 2/1 0 1/1 3/3 1/1 2/1 2/2 1/1 413* 7/7*
days 12-14 of gestation. Three fetuses in the group
given Dipterex only on day 8 of gestation had sev-
eral structural alterations, but their incidence did
not differ significantly from the Cv group in which
three nonstunted litter mates had cleft palates.
Comparison of the females given 10 mi/kg of
water t.i.d. (Cv) for various periods of gestation to
those not gavaged or handled several times a day
during pregnancy (C) revealed no significant change
in food consumption, maternal weight gain, mainte-
nance of pregnancy, fetal survival, or fetal de-
velopment to day 18 ofgestation (Tables 5 to 10).
Discussion
In a previous study (3), Dipterex was found to be
teratogenic in the rat if consumed at dose levels of
432 or 519mg/kgbody weight/day on days 6through
15 ofgestation, but not ifgivenby gavage oncedaily
forthe same period even at doses that were lethal to
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300 400 500 600
Ca Cvb mg/kg-day mg/kg-day mg/kg-day mg/kg-day
Females
Mortality 1 1
Number pregnant 12 23 7 4 6 20
Food intake, gc 6.8 ± 0.24 6.6 ± 0.16 6.4 ± 0.34 6.2 ± 0.35 6.0 ± 0.22d 5.5 ± 0.1 de
Weight gain, ge 11.0 + 0.59 10.0 ± 0.44 8.6 ± 0.96 7.1 ± I.Old 6.0 ± 0.95d 5.3 ± 0.48d'
Fetuses
Total number 135(11.2) 267(11.6) 91(13.0) 44(11.0) 67(11.2) 205(10.2)
Fetal death, % 12.9 ± 1.70 9.3 ± 1.64 12.5 ± 7.12 16.8 ± 4.34 13.3 ± 3.79 16.1 + 2.40
Number stunted (%)0 0 0 0 0 4(1.95)
Weight, g 0.95 ± 0.028 0.94 ± 0.013 0.86 ± 0.019d 0.84 ± 0.041d 0.80 ± 0.026d 0.80 ± 0.017de
Number malformed (%) 1(0.7 ± 0.69) 2(0.8 ± 0.79) 2(2.0 ± 1.33) 1(2.5 ± 2.50) 4(6.5 ± 3.56)d 7(4.0 ± 1.28)'
a C: group not gavaged.
b Cv: group gavaged (t.i.d.) with distilled water for the days indicated.
c Included the period gavaged plus two more days (X ± SE).
d p <0.05.
Significant dose response.
Table 8. Effect of Dipterex administration by gavage (t.i.d.) to CD-1 mice for day 8 and days 8-10 of gestation.
Day 8 Days 8-10
600 600
Ca Cv' mg/kg-day Ca Cv' mg/kg-day
Females
Mortality 1
Number pregnant 11 13 28 11 14 18
Food intake, gr 6.3 ± 0.37 5.7 ± 0.16 5.6 ± 0.11 6.9 ± .24 6.7 ± .33 5.9 ± .18d
Weight gain, gr 0.54 ± 0.217 0.08 ± 0.224 0.07 ± 0.142 3.0 ± .30 2.4 ± .36 1.4 ± .38
Fetuses
Total number 122(11.1) 149(11.4) 293(10.5) 121(11.0) 156(11.1) 200(11.1)
Fetal death, % 13.6 ± 2.48 10.7 ± 1.96 18.2 ± 3.02 12.3 ± 1.84 7.8 + 2.45 8.6 ± 1.82
Stunted, (%) 0 0 2(0.68) 0 0 1(0.50)
Weight, g 0.96 ± 0.023 0.91 ± 0.023 0.88 ± 0.013 0.93 ± 0.037 0.93 ± 0.037 0.86 ± 0.023
Malformed, (%) 0 5(3.5 ± 2.42) 4(2.1 ± 1.26) 1(0.8 ± 0.75) 1(0.9 ± 0.89) 0
a C: group not gavaged.
b Cv: group gavaged (t.i.d.) with distilled water for the days indicated.
c Included the period gavaged plus two more days (X ± SE).
d p < 0.05.
Table 9. Effect of Dipterex administration by gavage (t.i.d.) to CD-1 mice on days 10-12 and days 12-14 of gestation.
Days 10-12 Days 12-14
Cva 600 mg/kg-day Cb Cva 600 mg/kg-day
Females
Mortality
Number pregnant 2 4 14 16 26
Food intake, gr 6.3 ± 0.60 5.0 ± 0.07 7.2 ± 0.31 6.8 ± 0.14 6.1 ± 0.18d
Weight gain, g' 5.3 ± 1.00 1.2 ± 0.72d 6.9 ± 0.82 5.3 ± .59 4.2 ± .47
Fetuses
Total number 23(11.5) 49(12.2) 156(11.1) 185(11.6) 306(11.8)
Fetal death, % 17.8 ± 3.55 14.3 ± 4.74 15.3 ± 3.92 9.7 ± 2.40 14.1 ± 2.0
Number stunted (%) 0 0 1(0.64) 0 1(0.33)
Weight, g 0.92 ± 0.045 0.82 ± 0.026d 0.96 ± 0.021 0.95 ± 0.020 0.86 0 0.015d
Number malformed (%) 0 0 0 1(0.4 ± 0.44) 4(1.2 ± 0.58)
a CV: group gavaged (t.i.d.) with distilled water for the days indicated.
b C: group not gavaged.
c Included the period gavaged plus two more days (X ± SE).
dp < 0.05.
illl June 1979Table 10. Incidence ofalterations among the fetuses of CD-I mice given Dipterex by gavage (t.i.d.) on day 8, days 8-10, days 10-12, and
days 12-14.
Day 8 Days 8-10 Days 10-12 Days 12-14
600 600 600 600
C" Cvb mg/kg C" Cvb mg/kg-day Cv' mg/kg-day C'" Cv" mg/kg-day
Number of fetuses/number of litters
External alterations 122/11 149/13 293/28 121/11 156/14 200/18 23/2 49/4 156/14 185/16 306/26
Visceral alterations 50/11 55/13 117/28 47/11 61/14 80/18 8/2 18/4 61/14 72/16 114/26
Skeletal alterations 122/11 149/13 293/28 121/11 156/14 200/18 23/2 49/4 156/14 185/16 306/26
External examination
Cleft palate 3/1 41'
Exencephaly 1/1
Ablepharia 1/1
Umbilical hernia
Kinked tail
Clubbed limbs
Hematoma
Visceral examination
Hydrocephaly 1/1
Testes small
Lungs small 1/1
Skeletal examination
Vertebrae fused arch 1/1
Vertebrae doubled centra
Ribs missing
Ribs wavy 1/1
Sternebrae fused 1/1 1/1
Total affected 0 3/1 3/3 1/1 1/1 0 0 0 0 1/1 4/4
"1C: group not gavaged.
b CV: group gavaged (t.i.d.) with distilled water for the days indicated.
' p < 0.05.
some of the dams (150 to 250 mg/kg-day). In the
current study a positive teratogenic response
roughly equivalent to that obtained in the former
study was achieved by administration of Dipterex
by gavage (t.i.d.). By dividing the daily dose into
three equal portions, given roughly 3 hr apart, Dip-
terex could be administered at 480 mg/kg-day on
days 6 through 15 of gestation without causing a
significant increase in maternal lethality. Use of a
pair-fed control group demonstrated that the
teratogenicity seen was not due to decreased food
intake during the dosing period or to the stress of
extended t.i.d. administration. The positive
teratogenic response was not obtained if Dipterex
was given (t.i.d.) for only one day of gestation (on
day 8 or 10). Hence, the positive teratogenicity seen
after administration ofthis chemical with atransient
pharmacologic action also could be demonstrated
after administration by gavage, provided the daily
dose was given in fractions. This is an important
consideration for those responsible for determining
the teratogenic potential of environmental chemi-
cals.
For the hamster, the maximum dose of Dipterex
tolerated by gavage (t.i.d.) on days 7 through 11 of
gestation was 400 mg/kg-day. A positive teratogenic
response was obtained at this dose level which in-
cluded edema, cleft palates, digital malformations,
fused ribs, and even one case of the rarely seen
absence or shortening of the long bones of the ex-
tremities. The incidence of malformed fetuses per
litter was not as high as seen in the rat but the spec-
trum ofmalformations obtained was very similar in
both species. Again comparison to a pair-fed con-
trol group revealed that the malformations were not
merely due to reduced food intake. Statistically, the
apparent "no-effect" dose was 200 mg/kg-day, in
that significant differences from the control group
were not obtained in the dams or their offspring for
the criteria under study. Embryotoxicity, but not
teratogenicity, was evident after administration of
Dipterex at 400 mg/kg-day by gavage (t.i.d.) on day
8 of gestation. Fused ribs were seen, but they oc-
curred in three littermates among the 22 litters ex-
posed as well as in one fetus from the control group.
Hence, Dipterex had to be givenby gavage for more
than one day to demonstrate its teratogenicity in the
hamster.
The mouse was less susceptible to Dipterex than
the rat or hamster upon consideration ofthe dosage
administered without display ofcholinesterase inhi-
bition. The specific reason for this species differ-
Environmental Health Perspectives 112ence was not ascertained in the present study, but
the trend also was evident in the offspring. A posi-
tive teratogenic response was obtained at the high-
est doses tested but only when the Dipterex was
given on days 10 through 14 or 12 through 14 of
gestation. Dipterex related malformations consisted
mostly of cleft palates present in one-quarter to
one-sixth of the litters exposed, respectively.
Therefore, the teratogenicity ofDipterex was not
unique to the rat but was present also in the hamster
and to a lesser extent in the mouse. In each species
adverse effects on the conceptus occurred only at
doses that decreased maternal food consumption,
however, at least in the rat and hamster, the
teratogenicity was not merely due to the decreased
level offood consumed.
The authors thank R. G. Keliam for providing excellent tech-
nical assistance for the portion of this study dealing with rats,
and J. K. Haseman for providing statistical assistance. The
fetuses was examined for defects by Research Triangle Institute
under Contract #NIH-74-C-390. The Dipterex used was kindly
donated by Chemagro, Inc., Kansas City, Missouri.
REFERENCES
1. Staples, R. E., Keliam, R. G., and Haseman, J. K. Develop-
mental toxicity in the rat after ingestion or gavage of or-
ganophosphate pesticides (dipterex, imidan) during preg-
nancy. Environ. Health Perspect. 13: 133 (1976).
2. Staples, R. E. Detection ofvisceral alterations in mammalian
fetuses. Teratology 9: No. 3, A37 (1974).
3. Staples, R. E., and Schnell, V. L. Refinements in rapid
clearing technic in the KOH-Alizarin Red S method for fetal
bone. Stain Technol. 39: 62 (1964).
4. Seigel, S. Nonparametric Statistics for the Behavioral Sci-
ences. McGraw-Hill, New York, 1956, pp. 75-83, 116-127.
June 1979 113